Maharashtra, India

Vikas Daulatrao Ahirao

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.3

ph-index = 1


Company Filing History:


Years Active: 2012-2016

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Vikas Daulatrao Ahirao: Innovator in Pharmaceutical Patents

Introduction

Vikas Daulatrao Ahirao is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel solid-state forms of tapentadol salts. With a total of 3 patents to his name, Ahirao's work is recognized for its potential impact on pain management therapies.

Latest Patents

Ahirao's latest patents focus on the innovative solid-state forms of tapentadol salts. These patents detail the processes for their preparation, pharmaceutical compositions, and methods of treatment. The tapentadol salts include various forms such as L-(−)-camphorsulfonate salt, dibenzoyl-(L)-tartrate salt, dibenzoyl-(D)-tartrate salt, malate salt, maleate salt, and salicylate salt. This research aims to enhance the efficacy and stability of pain relief medications.

Career Highlights

Vikas Daulatrao Ahirao is currently associated with Actavis Group Ptc Ehf, where he continues to innovate in the pharmaceutical sector. His work has contributed to advancements in drug formulation and delivery systems, showcasing his commitment to improving patient care through scientific research.

Collaborations

Ahirao collaborates with talented professionals in his field, including Mayur Devjibhai Khunt and Sandipan Prabhurao Bondge. These collaborations foster a creative environment that enhances the development of new pharmaceutical solutions.

Conclusion

Vikas Daulatrao Ahirao stands out as a dedicated inventor in the pharmaceutical industry, with a focus on innovative solutions for pain management. His contributions through patents and collaborations reflect his commitment to advancing healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…